Cyient DLM shares fell nearly 19% after Q2FY27 results showed margin pressure and execution challenges, despite a 43% rise in net profit, 25% revenue growth and a record ₹2,810 crore order book. Brokerages split, with PL Capital rating the stock Reduce and Motilal Oswal maintaining Buy.
Cyient DLM shares fell nearly 19% after Q2FY27 results showed margin pressure and execution challenges, despite a 43% rise in net profit, 25% revenue growth and a record ₹2,810 crore order book. Brokerages split, with PL Capital rating the stock Reduce and Motilal Oswal maintaining Buy.
<iframe src="https://hindustansphere.com/embed/cluster/7834f2d2b3e9ec68003eff72d10abd8c7d502b41" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Cyient DLM share price crashes 19% after Q2 results but up 213% from 52-week low: Should you buy? Check target prices"></iframe>
